Literature DB >> 2318217

Comparison of four methods for testing high-level aminoglycoside resistance in enterococci.

P Yagupsky1, S Petry, M A Menegus.   

Abstract

In a prospective study the prevalence of high-level aminoglycoside resistance (MIC greater than or equal to 2,000 micrograms/ml) among 62 clinically significant enterococci was investigated. A total of 10(5) organisms were inoculated a) onto a plate containing 2,000 micrograms/ml of gentamicin or streptomycin; b) into a microtube for dilution MIC determinations for gentamicin, amikacin, tobramycin and streptomycin; and c) into a single tube containing 500 micrograms/ml of gentamicin, amikacin, tobramycin or streptomycin in supplemented Mueller-Hinton broth. In addition, tubes containing 500 micrograms/ml of gentamicin, amikacin, tobramycin or streptomycin were inoculated with five enterococcal colonies ("crude" method). For 45 of the 62 isolates, MICs of gentamicin, amikacin and tobramycin were less than or equal to 500 micrograms/ml, while 17 (27%) showed high-level resistance. The MICs of streptomycin were less than or equal to 500 micrograms/ml for 42 of 62 isolates, and greater than or equal to 2,000 micrograms/ml for 20 (32.3%). For 8 of the 17 (47%) isolates showing high-level gentamicin resistance, MICs of streptomycin were less than or equal to 500 micrograms/ml. There was complete agreement between the results of the plate method, the microtube dilution MIC and the tube inoculated with 10(5) CFU, but the crude method gave discordant results for two isolates. It is concluded that a tube containing 500 micrograms/ml of aminoglycoside is a simple, accurate and inexpensive method for determining high-level aminoglycoside resistance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318217     DOI: 10.1007/bf01963639

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

Review 1.  Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci.

Authors:  A L Bisno; W E Dismukes; D T Durack; E L Kaplan; A W Karchmer; D Kaye; S H Rahimtoola; M A Sande; J P Sanford; C Watanakunakorn
Journal:  JAMA       Date:  1989-03-10       Impact factor: 56.272

2.  Multiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospital.

Authors:  I Nachamkin; P Axelrod; G H Talbot; S H Fischer; C B Wennersten; R C Moellering; R R MacGregor
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

3.  Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci.

Authors:  M J Zervos; J E Patterson; S Edberg; C Pierson; C A Kauffman; T S Mikesell; D R Schaberg
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

4.  Antibiotic synergism of enterococci. Relation to inhibitory concentrations.

Authors:  H D Standiford; J B De Maine; W M Kirby
Journal:  Arch Intern Med       Date:  1970-08

5.  Emergence of Streptococcus faecalis isolates with high-level resistance to multiple aminocyclitol aminoglycosides.

Authors:  D P Ikeda; A L Barry; S G Andersen
Journal:  Diagn Microbiol Infect Dis       Date:  1984-06       Impact factor: 2.803

6.  High-level resistance to gentamicin in clinical isolates of enterococci.

Authors:  B D Mederski-Samoraj; B E Murray
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

7.  Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis.

Authors:  D F Sahm; C Torres
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

8.  High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy against Enterococcus faecalis.

Authors:  D F Sahm; C Torres
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

  8 in total
  6 in total

1.  Testing for high-level aminoglycoside resistance in enterococcal infections.

Authors:  B Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

2.  Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; P C Iwen; J L Baade; G L Woods
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

3.  Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards.

Authors:  D Weissmann; J Spargo; C Wennersten; M J Ferraro
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

4.  Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; J E Schulz
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

5.  New high-content disks for determination of high-level aminoglycoside resistance in clinical isolates of Enterococcus faecalis.

Authors:  R Leclercq; R Bismuth; J Duval
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

6.  Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci.

Authors:  J M Swenson; M J Ferraro; D F Sahm; N C Clark; D H Culver; F C Tenover
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.